Continuum Advisory’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-610
| Closed | -$55.6K | – | 1262 |
|
|
2025
Q1 | $55.6K | Hold |
610
| – | – | 0.01% | 647 |
|
|
2024
Q4 | $52.7K | Buy |
610
+3
| +0.5% | +$259 | 0.01% | 651 |
|
|
2024
Q3 | $53.6K | Buy |
607
+5
| +0.8% | +$441 | 0.01% | 642 |
|
|
2024
Q2 | $55.1K | Hold |
602
| – | – | 0.01% | 597 |
|
|
2024
Q1 | $53.8K | Buy |
+602
| New | +$53.8K | 0.01% | 588 |
|
|
2023
Q4 | – | Sell |
-2,906
| Closed | -$232K | – | 482 |
|
|
2023
Q3 | $232K | Buy |
2,906
+101
| +4% | +$8.07K | 0.04% | 403 |
|
|
2023
Q2 | $221K | Buy |
2,805
+2
| +0.1% | +$158 | 0.04% | 415 |
|
|
2023
Q1 | $218K | Sell |
2,803
-870
| -24% | -$67.5K | 0.04% | 398 |
|
|
2022
Q4 | $286K | Buy |
+3,673
| New | +$286K | 0.05% | 350 |
|